1. Kononczuk K, Muszynska-Roslan K, Konstantynowicz-Nowicka K, Krawczuk-Rybak M, Chabowski A, Latoch E. Biomarkers of glucose metabolism alterations and the onset of metabolic syndrome in survivors of childhood acute lymphoblastic leukemia. Int J Mol Sci. 2022; 23:3712.
Article
2. Bahoush G, Salajegheh P, Rohani F. Association between body mass index and insulin resistance in survivors of pediatric acute lymphoblastic leukemia. Leuk Res Rep. 2020; 13:100199.
Article
3. Pluimakers VG, van Waas M, Neggers S, van den Heuvel-Eibrink MM. Metabolic syndrome as cardiovascular risk factor in childhood cancer survivors. Crit Rev Oncol Hematol. 2019; 133:129–41.
Article
4. Sonabend RY, McKay SV, Okcu MF, Yan J, Haymond MW, Margolin JF. Hyperglycemia during induction therapy is associated with poorer survival in children with acute lymphocytic leukemia. J Pediatr. 2009; 155:73–8.
Article
5. Gregoriou K, Craigie I, Gibson B, Mason A, Shaikh MG. Risk factors and management of corticosteroid-induced hyperglycaemia in paediatric acute lymphoblastic leukaemia. Pediatr Blood Cancer. 2020; 67:e28085.
6. Handattu K, Sharma LK, Vijayasekharan K, Bhat KV, Aroor S, Sudhanshu S. Drug induced diabetes mellitus in pediatric acute lymphoblastic leukemia: approach to diagnosis and management. J Pediatr Hematol Oncol. 2022; 44:273–9.
Article
7. Williams HE, Howell CR, Chemaitilly W, Wilson CL, Karol SE, Nolan VG, et al. Diabetes mellitus among adult survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude Lifetime Cohort Study. Cancer. 2020; 126:870–8.
Article
8. Chan CL, Pyle L, Kelsey M, Newnes L, Zeitler PS, Nadeau KJ. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin. Pediatr Diabetes. 2016; 17:206–11.
Article
9. Spencer DH, Grossman BJ, Scott MG. Red cell transfusion decreases hemoglobin A1c in patients with diabetes. Clin Chem. 2011; 57:344–6.
Article
10. Wei C, Unsworth R, Davis N, Cox R, Bradley K, Stevens M, et al. Survivors of childhood leukaemia treated with haematopoietic stem cell transplantation and total body irradiation should undergo screening for diabetes by oral glucose tolerance tests. Diabet Med. 2016; 33:1347–51.
Article
11. Chan CL, McFann K, Newnes L, Nadeau KJ, Zeitler PS, Kelsey M. Hemoglobin A1c assay variations and implications for diabetes screening in obese youth. Pediatr Diabetes. 2014; 15:557–63.
Article
12. Musha I, Mochizuki M, Kikuchi T, Akatsuka J, Ohtake A, Kobayashi K, et al. Estimation of glycaemic control in the past month using ratio of glycated albumin to HbA1c. Diabet Med. 2018; 35:855–61.
13. American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019; 42(Suppl 1):S13–28.
14. Kim JH, Yun S, Hwang SS, Shim JO, Chae HW, Lee YJ, et al. The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects. Korean J Pediatr. 2018; 61:135–49.
Article
15. Zemlin AE, Barkhuizen M, Kengne AP, Erasmus RT, Matsha TE. Performance of glycated albumin for type 2 diabetes and prediabetes diagnosis in a South African population. Clin Chim Acta. 2019; 488:122–8.
Article
16. Hashimoto K, Osugi T, Noguchi S, Morimoto Y, Wasada K, Imai S, et al. A1C but not serum glycated albumin is elevated because of iron deficiency in late pregnancy in diabetic women. Diabetes Care. 2010; 33:509–11.
Article
17. Sugawara D, Sato H, Makita E, Kuwata T, Takagi K, Ichihashi K. Clinical usefulness of glycated albumin and glycated albumin-to-glycated hemoglobin ratio of gestational diabetes mellitus in late pregnancy for predicting infant complications. Pediatr Neonatol. 2022; 63:239–46.
Article
18. Kim Y, Lee SH, Kang MK, Kim TJ, Jeong HY, Lee EJ, et al. Glycated albumin, a novel biomarker for short-term functional outcomes in acute ischemic stroke. Brain Sci. 2021; 11:337.
Article
19. Vos FE, Schollum JB, Walker RJ. Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease. NDT Plus. 2011; 4:368–75.
Article
20. Rescalli A, Varoni EM, Cellesi F, Cerveri P. Analytical challenges in diabetes management: towards glycated albumin point-of-care detection. Biosensors (Basel). 2022; 12:687.
21. Desouza CV, Holcomb RG, Rosenstock J, Frias JP, Hsia SH, Klein EJ, et al. Results of a study comparing glycated albumin to other glycemic indices. J Clin Endocrinol Metab. 2020; 105:677–87.
Article
22. Nishimura R, Kanda A, Sano H, Matsudaira T, Miyashita Y, Morimoto A, et al. Glycated albumin is low in obese, non-diabetic children. Diabetes Res Clin Pract. 2006; 71:334–8.
Article
23. Wallace AS, Rooney MR, Brady TM, Echouffo-Tcheugui JB, Christenson R, Grams ME, et al. The performance of glycated albumin as a biomarker of hyperglycemia and cardiometabolic risk in children and adolescents in the United States. Pediatr Diabetes. 2022; 23:237–47.
Article
24. Ribeiro RT, Macedo MP, Raposo JF. HbA1c, Fructosamine, and glycated albumin in the detection of dysglycaemic conditions. Curr Diabetes Rev. 2016; 12:14–9.
Article
25. Pollock NI, Flamand Y, Zhu J, Millington K, Stevenson K, Silverman LB, et al. Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration. Pediatr Blood Cancer. 2022; 69:e29505.
Article
26. Chueh HW, Yoo JH. Metabolic syndrome induced by anticancer treatment in childhood cancer survivors. Ann Pediatr Endocrinol Metab. 2017; 22:82–9.
Article
27. Kartal I, Alacam A, Dagdemir A, Kara C, Dincer OS, Albayrak C, et al. Frequency of obesity and metabolic syndrome in childhood leukemia and lymphoma survivors. Diabetol Metab Syndr. 2022; 14:16.
Article
28. Suwa T, Ohta A, Matsui T, Koganei R, Kato H, Kawata T, et al. Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM). Endocr J. 2010; 57:135–40.
Article
29. McCormick MC, Sharp E, Kalpatthi R, Zullo J, Gurtunca N, Zhang J, et al. Hyperglycemia requiring insulin during acute lymphoblastic leukemia induction chemotherapy is associated with increased adverse outcomes and healthcare costs. Pediatr Blood Cancer. 2020; 67:e28475.
Article
30. Saultier P, Auquier P, Bertrand Y, Vercasson C, Oudin C, Contet A, et al. Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study. Haematologica. 2016; 101:1603–10.
Article
31. Brignardello E, Felicetti F, Castiglione A, Chiabotto P, Corrias A, Fagioli F, et al. Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics. Eur J Endocrinol. 2013; 168:465–72.
Article
32. Piona C, Marigliano M, Mozzillo E, Rosanio F, Zanfardino A, Iafusco D, et al. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2021; 177:108933.
Article
33. Desouza CV, Rosenstock J, Zhou R, Holcomb RG, Fonseca VA. Glycated albumin at 4 weeks correlates with a1c levels at 12 weeks and reflects short-term glucose fluctuations. Endocr Pract. 2015; 21:1195–203.
Article
34. Sugimoto T, Hashimoto M, Hayakawa I, Tokuno O, Ogino T, Okuno M, et al. Alterations in HbA1c resulting from the donation of autologous blood for elective surgery in patients with diabetes mellitus. Blood Transfus. 2014; 12 Suppl 1(Suppl 1):s209–13.
35. Janice D, Prathima MB, Sushith S, Narayanan R, Reshma S, Nair S, et al. Effect of iron deficiency anaemia over glycated hemoglobin in non-diabetic women. Int J Biochem Mol Biol. 2022; 13:23–7.
36. Koga M, Otsuki M, Matsumoto S, Saito H, Mukai M, Kasayama S. Negative association of obesity and its related chronic inflammation with serum glycated albumin but not glycated hemoglobin levels. Clin Chim Acta. 2007; 378:48–52.
Article
37. Kim M, Kim J. Cardiometabolic risk factors and metabolic syndrome based on severity of obesity in Korean children and adolescents: data from the Korea National Health and Nutrition Examination Survey 2007-2018. Ann Pediatr Endocrinol Metab. 2022; 27:289–99.
Article
38. Kim JH, Lim JS. The association between C-reactive protein, metabolic syndrome, and prediabetes in Korean children and adolescents. Ann Pediatr Endocrinol Metab. 2022; 27:273–80.
Article
39. Park HK, Seo JY, Jung HW, Lim JS. Prevalence and trends in obesity and severe obesity in Korean children and adolescents, 2007-2020: a population-based study. Pediatr Int. 2023; 65:e15472.
Article
40. Kang HM, Jeong DC, Suh BK, Ahn MB. The impact of the coronavirus disease-2019 pandemic on childhood obesity and vitamin D status. J Korean Med Sci. 2021; 36:e21.